2021Journal of genetics and molecular biologyRequires access

Editorial Note on Metabolic Syndrome.

Fleur Delacour

Open publisher page 0 citations

Abstract

One of the most common causes of atherosclerotic vascular disease and type 2 diabetes is metabolic syndrome (MS) (Type 2 DM). Metabolic syndrome is characterised by abdominal obesity, insulin resistance, high blood pressure, and lipid disorders. The metabolic syndrome's prevalence rises with age and body weight, as well as through populations studied at the same time. The prevalence of metabolic syndrome is 27 percent in the United States, and the prevalence of metabolic syndrome is growing faster in women. In Turkey, metabolic syndrome affects 38% of the population.

About this research paper

What this paper is about

One of the most common causes of atherosclerotic vascular disease and type 2 diabetes is metabolic syndrome (MS) (Type 2 DM). Metabolic syndrome is characterised by abdominal obesity, insulin resistance, high blood pressure, and lipid disorders. The metabolic syndrome's prevalence rises with age and body weight, as well as through populations studied at the same time. The prevalence of metabolic syndrome is 27 percent in the United States, and the prevalence of metabolic syndrome is growing faster in women. In Turkey, metabolic syndrome affects 38% of the population.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

One of the most common causes of atherosclerotic vascular disease and type 2 diabetes is metabolic syndrome (MS) (Type 2 DM). Metabolic syndrome is characterised by abdominal obesity, insulin resistance, high blood pressure, and lipid disorders. The metabolic syndrome's prevalence rises with age and body weight, as well as through populations studied at the same time. The prevalence of metabolic syndrome is 27 percent in the United States, and the prevalence of metabolic syndrome is growing faster in women. In Turkey, metabolic syndrome affects 38% of the population.

Key concepts: Metabolic syndrome, Insulin resistance, Medicine, Obesity, Type 2 diabetes, Abdominal obesity, Internal medicine, Endocrinology

Related papers

Back to paper searchBrowse research topicsOriginal source
Editorial Note on Metabolic Syndrome. — Research Paper | ScholarLens